Establishes an ibogaine research fund to support clinical trials for ibogaine treatment of substance use disorders and other conditions.

The bill creates the ibogaine research and intellectual property fund to support clinical trials for ibogaine, a drug derived from the Tabernanthe iboga plant, for treating conditions such as opioid use disorder and post-traumatic stress disorder. The fund will receive $21 million from the opioid abatement trust fund for the 2026-2028 fiscal biennium. The Department of Agriculture will enter into a public-private partnership with a drug developer to conduct clinical trials, with the developer required to match the Commonwealth's investment and provide detailed reports on trial progress and.

Establishes an ibogaine research fund to support clinical trials for ibogaine treatment of substance use disorders and other conditions.

The bill creates the ibogaine research and intellectual property fund to support clinical trials for ibogaine, a drug derived from the Tabernanthe iboga plant, for treating conditions such as opioid use disorder and post-traumatic stress disorder. The fund will receive $21 million from the opioid abatement trust fund for the 2026-2028 fiscal biennium. The Department of Agriculture will enter into a public-private partnership with a drug developer to conduct clinical trials, with the developer required to match the Commonwealth's investment and provide detailed reports on trial progress and.